Related Experiment Videos
Participation of group 2 CD1 molecules in the control of murine tuberculosis
Insights
CD1 molecules play a crucial role in presenting antigens during tuberculosis. Modulating CD1 in vivo worsened disease and reduced key immune responses, suggesting CD1
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Major histocompatibility complex (MHC) class I and II molecules are classical antigen-presenting molecules.
- Human CD1 molecules have demonstrated in vitro capacity for presenting mycobacterial antigens.
- Tuberculosis remains a significant global health challenge requiring a deeper understanding of immune responses.
Purpose of the Study:
- To investigate the in vivo role of CD1 molecules in the context of tuberculosis.
- To assess the impact of CD1 modulation on host immune responses to Mycobacterium tuberculosis.
Main Methods:
- In vivo treatment of mice with anti-CD1 monoclonal antibodies.
- Assessment of tuberculosis exacerbation at early time points.
- Quantification of Mycobacterium tuberculosis-specific cytokine production, including IL-12, TNF, IFN-gamma, and TGF-beta.
Main Results:
- In vivo administration of anti-CD1 antibodies led to exacerbated tuberculosis.
- Exacerbation of disease was observed at very early time points post-infection.
- CD1-modulated mice exhibited reduced production of type 1 cytokines (IL-12, TNF, IFN-gamma) and TGF-beta.
Conclusions:
- CD1 molecules appear to have a significant antigen-presenting role in vivo during tuberculosis.
- Modulation of CD1 impacts key cytokine profiles, suggesting involvement in protective immunity.
- These findings highlight CD1 as a potential target for therapeutic strategies against tuberculosis.
Abstract:
Besides the classical major histocompatibility complex (MHC) class I and MHC class II molecules, human CD1 molecules have been shown to present mycobacterial antigens in vitro. In this study, in vivo treatment of mice with anti-CD1 monoclonal antibodies resulted in exacerbated tuberculosis at very early time points. In CD1-modulated mice, Mycobacterium tuberculosis-specific production of the type 1 cytokines, IL-12, TNF, and IFN-gamma as well as of TGF beta was reduced. These findings suggest an antigen-presenting role of CD1 molecules in tuberculosis.